Profiles of Drug Substances, Excipients, and Related Methodology
- 1st Edition, Volume 49 - February 29, 2024
- Imprint: Academic Press
- Editor: Abdulrahman Al-Majed
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 3 2 6 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 3 2 7 - 6
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 49 provides timely and pertinent information on a variety of timely topics, including Physical Profil… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteProfiles of Drug Substances, Excipients, and Related Methodology, Volume 49 provides timely and pertinent information on a variety of timely topics, including Physical Profiles of Drug Substances and Excipients; Analytical Profiles of Drug Substances and Excipients; ADME Profiles of Drug Substances and Excipients; Methodology Related to the Characterization of Drug Substances and Excipients; and Methods of Chemical Synthesis. In addition, it includes comprehensive profiles of five drug compounds: Deferasirox, Duvelisib, Regorafenib, Ponatinib and Avanafil. Finally, the book contains a chapter on Regulation and Standardization of Herbal Drugs: Current status, Limitation, Challenge’s, and Future Prospectives.
- Offers a comprehensive review of the biological, chemical, and physical characteristics of commonly prescribed medications
- Provides synthesis and pathways of physical or biological degradation of selected drug substances
- Presents the pharmacology of certain drug substances
- Describes nearly all analytical methods used to identify and quantify drug substances
Pharmacists, Pharmaceutical, medicinal, and analytical chemists, Pharmacologists, physicians, Dentist
- Cover image
- Title page
- Table of Contents
- Series Page
- Copyright
- Contributors
- Preface
- Chapter One: Deferasirox: A comprehensive drug profile
- Abstract
- 1 Description
- 2 Mode of action
- 3 Pharmacokinetics
- 4 Indications
- 5 Synthesis
- 6 Physical characteristics
- 7 Methods of analysis
- Acknowledgment
- References
- Chapter Two: Duvelisib: A comprehensive profile
- Abstract
- 1 Description
- 2 Uses and applications
- 3 Methods of preparation
- 4 Spectroscopic analysis
- 5 Thermogravimetric analysis
- 6 Methods of analysis
- 7 Pharmacological properties
- 8 Dosing information
- References
- Chapter Three: Regorafenib: A comprehensive drug profile
- Abstract
- 1 Description
- 2 Physical characteristics
- 3 Methods of preparation
- 4 Methods of analysis
- 5 Pharmacology
- References
- Chapter Four: Ponatinib: A comprehensive drug profile
- Abstract
- Abbreviations
- 1 General information
- 2 Physical characteristics
- 3 Uses and applications
- 4 Stability
- 5 Preparation of ponatinib
- 6 Impurities
- 7 Reported methods of analysis
- 8 Clinical pharmacology
- References
- Chapter Five: Avanafil: A comprehensive drug profile
- Abstract
- 1 Description
- 2 Methods of preparation of avanafil
- 3 Physical characteristics
- 4 Methods of analysis
- 5 Stability
- 6 Clinical pharmacology of avanafil
- References
- Chapter Six: Regulation and standardization of herbal drugs: Current status, limitation, challenge’s and future prospective
- Abstract
- Abbreviations
- 1 Introduction
- 2 Regulation of herbal drugs
- 3 Standardization of herbal drugs: current criteria and limitations
- 4 Challenges and future perspective of HD standardization methods
- 5 Summary and recommendations
- Acknowledgments
- References
- Cumulative index
- Edition: 1
- Volume: 49
- Published: February 29, 2024
- Imprint: Academic Press
- No. of pages: 454
- Language: English
- Hardback ISBN: 9780443293269
- eBook ISBN: 9780443293276
AA
Abdulrahman Al-Majed
Professor Abdulrahman AlMajed obtained a Bachelor of Pharmaceutical Sciences from College of Pharmacy, King Saud University, Riyadh, Saudi Arabia in 1990 and a Ph.D. in the field of Pharmaceutical analytical Chemistry from the University of Bradford, UK, in 1997. He also received a Bachelor of Legislation from College of Legislation, Imam Mohammed Bin Saud University, Riyadh, Saudi Arabia. He was appointed as assistance professor in Pharmaceutical Chemistry Department at College of Pharmacy, King Saud University in 1998. He was promoted to the rank of associated professor in 2003. He was a head of Pharmaceutical Chemistry Department (2005-2019) (2015-2017). Since 2009, he is full professor of Pharmaceutical Analytical Chemistry. He was assistance secretary of Scientific Council at King Saud University and he is presently a member of Scientific Council in Princess Nourah Bint Abdul Rahman University and in Jouf University, Saudi Arabia. He also a member of Medical and health Sciences Committee of Qualification Recognition in Ministry of Education and a member of Patent Lawsuits Committee in Saudi Arabia. He is a member of several scientific and social Committees. He participated in several national and international conferences and symposia. Prof. Almajed has taught courses in the field of Pharmaceutical Analysis at both the undergraduate and postgraduate levels at College of Pharmacy. He is recently appointed as the Editor-In-Chief of the book series Profiles of Drug Substances, Excipients, and Related Methodology. He published 10 chapters in the series. Dr. AlMajed published over 65 research papers in the field of Pharmaceutical Analysis. His research is focused on determination and validation of pharmaceutical compounds in dosage forms or/and in biological fluids by analytical techniques including: HPLC, electrophoresis, spectrophotometry, spectrofluorometry, voltammetry. His research also includes resolution and quantitation of the R-(-)- and S-(+)- enantiomers of pharmaceutical compounds in dosage forms or/and in biological fluids using chiral stationary phases.
Affiliations and expertise
Professor, Pharmaceutical Chemistry Department, College of Pharmacy, King Saud University, Saudi ArabiaRead Profiles of Drug Substances, Excipients, and Related Methodology on ScienceDirect